News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Opinion Editor's Corner Las Noticias y Blogs Más Populares de TCTMD en 2016 Shelley Wood December 29, 2016
News Daily News El Informe de AHA/ACC Recomienda 10 Medidas para Evitar la Muerte Cardíaca Súbita Leah Lawrence December 23, 2016
News Daily News AHA/ACC Report Recommends 10 Measures to Prevent Sudden Cardiac Death Leah Lawrence December 23, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2016 Shelley Wood November 30, 2016
News Daily News Tricky Population of Patients With A-fib Undergoing PCI Tackled in New Consensus Document Todd Neale November 29, 2016
News Conference News AHA 2016 Errar la Dosis de NOAC en la Práctica Clínica Diaria es algo Habitual, lo cual tiene Implicaciones en Materia de ACV y Hemorragias Shelley Wood November 21, 2016
News Conference News AHA 2016 Subclinical A-fib Common in Older, Asymptomatic Patients Todd Neale November 18, 2016
News Conference News AHA 2016 La FA Subclínica es Común en Pacientes Asintomáticos de Mayor Edad Todd Neale November 18, 2016
News Conference News AHA 2016 Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results Todd Neale November 15, 2016
News Conference News AHA 2016 Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI Todd Neale November 14, 2016
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Opinion Editor's Corner TCT 2016 Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones Shelley Wood November 07, 2016
Presentation TCT 2016 The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status Presenter: Freek W.A. Verheugt, Pascal Vranckx, Deepak L. Bhatt November 01, 2016
Presentation TCT 2016 The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status Presenter: Freek W.A. Verheugt, Pascal Vranckx, Roxana Mehran November 01, 2016
Presentation TCT 2016 The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status Presenter: Freek W.A. Verheugt, Pascal Vranckx November 01, 2016
Presentation TCT 2016 The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status Presenter: Freek W.A. Verheugt, Pascal Vranckx, C. Michael Gibson November 01, 2016
News Daily News Short Bouts of Atrial Tachyarrhythmia Do Not Worsen Prognosis, Study Suggests Todd Neale October 19, 2016
News Daily News La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular Michael O'Riordan October 18, 2016